Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1562

1.

Race, tumor location, and disease progression among low-risk prostate cancer patients.

Mygatt JG, Cullen J, Streicher SA, Kuo HC, Chen Y, Young D, Gesztes W, Williams G, Conti G, Porter C, Stroup SP, Rice KR, Rosner IL, Burke A, Sesterhenn I.

Cancer Med. 2020 Jan 21. doi: 10.1002/cam4.2864. [Epub ahead of print]

2.

Intestinal microbes influence development of thymic lymphocytes in early life.

Ennamorati M, Vasudevan C, Clerkin K, Halvorsen S, Verma S, Ibrahim S, Prosper S, Porter C, Yeliseyev V, Kim M, Gardecki J, Sassi S, Tearney G, Cherayil BJ, Bry L, Seed B, Jain N.

Proc Natl Acad Sci U S A. 2020 Jan 21. pii: 201915047. doi: 10.1073/pnas.1915047117. [Epub ahead of print]

PMID:
31964813
3.

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.

Ann Oncol. 2020 Feb;31(2):171-190. doi: 10.1016/j.annonc.2019.10.023.

PMID:
31959335
4.

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.

Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA.

J Clin Oncol. 2020 Jan 15:JCO1902757. doi: 10.1200/JCO.19.02757. [Epub ahead of print]

PMID:
31940221
5.

Development of the NEC-Zero Toolkit: Supporting Reliable Implementation of Necrotizing Enterocolitis Prevention and Recognition.

Gephart SM, Newnam K, Wyles C, Bethel C, Porter C, Quinn MC, Canvasser J, Umberger E, Titler M.

Neonatal Netw. 2020 Jan 1;39(1):6-15. doi: 10.1891/0730-0832.39.1.6.

PMID:
31919288
6.

The measurement of pediatric inpatient nursing using the Complexity Assessment and Monitoring to Ensure Optimal Outcomes (CAMEO©) tool.

Connor JA, LaGrasta C, Porter C, Hurtig M, McHugh S, King E, Atkinson C, Hickey PA.

J Pediatr Nurs. 2019 Dec 27;51:42-48. doi: 10.1016/j.pedn.2019.12.005. [Epub ahead of print]

PMID:
31887720
7.

Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.

Tay E, Nguyen TH, Ford L, Williams HD, Benameur H, Scammells PJ, Porter CJH.

Pharmaceutics. 2019 Dec 22;12(1). pii: E17. doi: 10.3390/pharmaceutics12010017.

8.

Metachronous mediastinal and lung metastases from head and neck cancer: A case series, literature review and considerations for treatment.

Ampil F, Previgliano C, Porter C, Richards T, Takalkar A.

Oral Oncol. 2019 Dec 17:104518. doi: 10.1016/j.oraloncology.2019.104518. [Epub ahead of print]

PMID:
31862239
9.

Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies.

Talaat KR, Bourgeois AL, Frenck RW, Chen WH, MacLennan CA, Riddle MS, Suvarnapunya AE, Brubaker JL, Kotloff KL, Porter CK.

Clin Infect Dis. 2019 Dec 9;69(Supplement_8):S580-S590. doi: 10.1093/cid/ciz892.

10.

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints.

MacLennan CA, Riddle MS, Chen WH, Talaat KR, Jain V, Bourgeois AL, Frenck R, Kotloff K, Porter CK.

Clin Infect Dis. 2019 Dec 9;69(Supplement_8):S591-S595. doi: 10.1093/cid/ciz891.

11.

GPR108 Is a Highly Conserved AAV Entry Factor.

Dudek AM, Zabaleta N, Zinn E, Pillay S, Zengel J, Porter C, Franceschini JS, Estelien R, Carette JE, Zhou GL, Vandenberghe LH.

Mol Ther. 2019 Nov 13. pii: S1525-0016(19)30501-5. doi: 10.1016/j.ymthe.2019.11.005. [Epub ahead of print]

PMID:
31784416
12.

The Political, Research, Programmatic, and Social Responses to Adolescent Sexual and Reproductive Health and Rights in the 25 Years Since the International Conference on Population and Development.

Chandra-Mouli V, Ferguson BJ, Plesons M, Paul M, Chalasani S, Amin A, Pallitto C, Sommers M, Avila R, Eceéce Biaukula KV, Husain S, Janušonytė E, Mukherji A, Nergiz AI, Phaladi G, Porter C, Sauvarin J, Camacho-Huber AV, Mehra S, Caffe S, Michielsen K, Ross DA, Zhukov I, Bekker LG, Celum CL, Dayton R, Erulkar A, Travers E, Svanemyr J, Maksud N, Digolo-Nyagah L, Diop NJ, Lhaki P, Adhikari K, Mahon T, Manzenski Hansen M, Greeley M, Herat J, Engel DMC.

J Adolesc Health. 2019 Dec;65(6S):S16-S40. doi: 10.1016/j.jadohealth.2019.09.011. Review.

PMID:
31761001
13.

Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, Khanal S, Butcher ET, Estrada BE, Rachubinski AL, McWilliams JA, Minter R, Dimasi T, Colvin KL, Baturin D, Pham AT, Galbraith MD, Bartsch KW, Yeager ME, Porter CC, Sullivan KD, Hsieh EW, Espinosa JM.

Cell Rep. 2019 Nov 12;29(7):1893-1908.e4. doi: 10.1016/j.celrep.2019.10.038.

14.

Safety of Biweekly Chlorhexidine Gluconate Bathing in Infants 36 To 48 Weeks' Postmenstrual Age.

Chandonnet CJ, Toole C, Young V, Feldman HA, Kellogg M, Kim J, Scoville M, Porter C, Weekes M, Wild S, DeGrazia M.

Am J Crit Care. 2019 Nov;28(6):451-459. doi: 10.4037/ajcc2019967.

PMID:
31676520
15.

Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats.

Styles IK, Feeney OM, Nguyen TH, Brundel DHS, Kang DW, Clift R, McIntosh MP, Porter CJH.

J Control Release. 2019 Dec 10;315:85-96. doi: 10.1016/j.jconrel.2019.10.040. Epub 2019 Oct 23.

PMID:
31655131
16.

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.

Luo X, Feurstein S, Mohan S, Porter CC, Jackson SA, Keel S, Chicka M, Brown AL, Kesserwan C, Agarwal A, Luo M, Li Z, Ross JE, Baliakas P, Pineda-Alvarez D, DiNardo CD, Bertuch AA, Mehta N, Vulliamy T, Wang Y, Nichols KE, Malcovati L, Walsh MF, Rawlings LH, McWeeney SK, Soulier J, Raimbault A, Routbort MJ, Zhang L, Ryan G, Speck NA, Plon SE, Wu D, Godley LA.

Blood Adv. 2019 Oct 22;3(20):2962-2979. doi: 10.1182/bloodadvances.2019000644.

17.

Childhood adversity and borderline personality disorder: a meta-analysis.

Porter C, Palmier-Claus J, Branitsky A, Mansell W, Warwick H, Varese F.

Acta Psychiatr Scand. 2020 Jan;141(1):6-20. doi: 10.1111/acps.13118. Epub 2019 Nov 18. Review.

PMID:
31630389
18.

Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties.

Lee G, Han S, Inocencio I, Cao E, Hong J, Phillips ARJ, Windsor JA, Porter CJH, Trevaskis NL.

Mol Pharm. 2019 Nov 1. doi: 10.1021/acs.molpharmaceut.9b00855. [Epub ahead of print]

PMID:
31625752
19.

Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide α-CGRP Modulates Group 2 Innate Lymphoid Cell Responses.

Xu H, Ding J, Porter CBM, Wallrapp A, Tabaka M, Ma S, Fu S, Guo X, Riesenfeld SJ, Su C, Dionne D, Nguyen LT, Lefkovith A, Ashenberg O, Burkett PR, Shi HN, Rozenblatt-Rosen O, Graham DB, Kuchroo VK, Regev A, Xavier RJ.

Immunity. 2019 Oct 15;51(4):696-708.e9. doi: 10.1016/j.immuni.2019.09.004.

PMID:
31618654
20.

Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Pogreba-Brown K, Austhof E, Armstrong A, Schaefer K, Villa Zapata L, McClelland DJ, Batz MB, Kuecken M, Riddle M, Porter CK, Bazaco MC.

Foodborne Pathog Dis. 2019 Oct 7. doi: 10.1089/fpd.2019.2692. [Epub ahead of print]

PMID:
31589475
21.

Effect of high-fat diet on peripheral blood mononuclear cells and adipose tissue in early stages of diet-induced weight gain.

Lowry JE, Tumurbaatar B, D'Agostino C, Main E, Wright TJ, Dillon EL, Saito TB, Porter C, Andersen CR, Brining DL, Endsley JJ, Sheffield-Moore M, Volpi E, Fang R, Abate N, Tuvdendorj DR.

Br J Nutr. 2019 Dec 28;122(12):1359-1367. doi: 10.1017/S0007114519002472.

22.

MLL1 is required for PAX7 expression and satellite cell self-renewal in mice.

Addicks GC, Brun CE, Sincennes MC, Saber J, Porter CJ, Francis Stewart A, Ernst P, Rudnicki MA.

Nat Commun. 2019 Sep 18;10(1):4256. doi: 10.1038/s41467-019-12086-9.

23.

Low skeletal muscle capillarization limits muscle adaptation to resistance exercise training in older adults.

Moro T, Brightwell CR, Phalen DE, McKenna CF, Lane SJ, Porter C, Volpi E, Rasmussen BB, Fry CS.

Exp Gerontol. 2019 Nov;127:110723. doi: 10.1016/j.exger.2019.110723. Epub 2019 Sep 10.

PMID:
31518665
24.

Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis.

Porter CM, Haffner MC, Kulac I, Maynard JP, Baena-Del Valle JA, Isaacs WB, Yegnasubramanian S, De Marzo AM, Sfanos KS.

Am J Pathol. 2019 Nov;189(11):2311-2322. doi: 10.1016/j.ajpath.2019.07.016. Epub 2019 Sep 6.

PMID:
31499027
25.

Acute flaccid myelitis: Rehabilitation challenges and outcomes in a pediatric cohort.

Melicosta ME, Dean J, Hagen K, Oppenheimer K, Porter C, Rybczynski S, Salorio C, Sadowsky C.

J Pediatr Rehabil Med. 2019;12(3):245-253. doi: 10.3233/PRM-180549.

PMID:
31476175
26.

A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.

Alsinnawi M, Cullen J, Hurwitz LM, Levie KE, Burns JF, Rosner IL, Brand TC, Stroup S, Sterbis JR, Rice K, Conti G, Porter CR.

Can J Urol. 2019 Aug;26(4):9809-9820.

PMID:
31469635
27.

Adult Health Status Among Native American Families Participating in the Growing Resilience Home Garden Study.

Porter CM, Wechsler AM, Hime SJ, Naschold F.

Prev Chronic Dis. 2019 Aug 22;16:E113. doi: 10.5888/pcd16.190021.

28.

Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Mitchell SG, Pencheva B, Porter CC.

Curr Oncol Rep. 2019 Aug 15;21(10):85. doi: 10.1007/s11912-019-0836-9. Review.

PMID:
31414239
29.

Engineering Biocoatings To Prolong Drug Release from Supraparticles.

Ma Y, Cortez-Jugo C, Li J, Lin Z, Richardson RT, Han Y, Zhou J, Björnmalm M, Feeney OM, Zhong QZ, Porter CJH, Wise AK, Caruso F.

Biomacromolecules. 2019 Sep 9;20(9):3425-3434. doi: 10.1021/acs.biomac.9b00710. Epub 2019 Aug 14.

PMID:
31411865
30.

Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates.

Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA.

Jt Comm J Qual Patient Saf. 2019 Oct;45(10):686-693. doi: 10.1016/j.jcjq.2019.06.001. Epub 2019 Jul 29.

PMID:
31371099
31.

Character displacement of a learned behaviour and its implications for ecological speciation.

Porter CK, Benkman CW.

Proc Biol Sci. 2019 Aug 14;286(1908):20190761. doi: 10.1098/rspb.2019.0761. Epub 2019 Jul 31.

PMID:
31362636
32.

How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?

Giersing BK, Porter CK, Kotloff K, Neels P, Cravioto A, MacLennan CA.

Vaccine. 2019 Aug 7;37(34):4778-4783. doi: 10.1016/j.vaccine.2019.03.036.

33.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2019 Jul 1;129(7):2980. doi: 10.1172/JCI130874. Epub 2019 Jul 1. No abstract available.

34.

ETV6-related thrombocytopenia and leukemia predisposition.

Di Paola J, Porter CC.

Blood. 2019 Aug 22;134(8):663-667. doi: 10.1182/blood.2019852418. Epub 2019 Jun 27.

PMID:
31248877
35.

Dissecting fat-tailed fluctuations in the cytoskeleton with active micropost arrays.

Shi Y, Porter CL, Crocker JC, Reich DH.

Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):13839-13846. doi: 10.1073/pnas.1900963116. Epub 2019 Jun 25.

36.

Stopping Leukemia in Its Tracks: Should Preemptive Hematopoietic Stem-Cell Transplantation be Offered to Patients at Increased Genetic Risk for Acute Myeloid Leukemia?

Hamilton KV, Maese L, Marron JM, Pulsipher MA, Porter CC, Nichols KE.

J Clin Oncol. 2019 Aug 20;37(24):2098-2104. doi: 10.1200/JCO.19.00181. Epub 2019 Jun 6. No abstract available.

PMID:
31170028
37.

Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms.

Williams HD, Ford L, Igonin A, Shan Z, Botti P, Morgen MM, Hu G, Pouton CW, Scammells PJ, Porter CJH, Benameur H.

Adv Drug Deliv Rev. 2019 Mar 1;142:75-90. doi: 10.1016/j.addr.2019.05.008. Epub 2019 May 29. Review.

PMID:
31150666
38.

The behavioral repertoire of Drosophila melanogaster in the presence of two predator species that differ in hunting mode.

Parigi A, Porter C, Cermak M, Pitchers WR, Dworkin I.

PLoS One. 2019 May 31;14(5):e0216860. doi: 10.1371/journal.pone.0216860. eCollection 2019.

39.

IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression.

Rabe JL, Gardner L, Hunter R, Fonseca JA, Dougan J, Gearheart CM, Leibowitz MS, Lee-Miller C, Baturin D, Fosmire SP, Zelasko SE, Jones CL, Slansky JE, Rupji M, Dwivedi B, Henry CJ, Porter CC.

Cancer Res. 2019 Jul 15;79(14):3702-3713. doi: 10.1158/0008-5472.CAN-18-3800. Epub 2019 May 29.

PMID:
31142509
40.

Moderate-intensity aerobic exercise improves skeletal muscle quality in older adults.

Brightwell CR, Markofski MM, Moro T, Fry CS, Porter C, Volpi E, Rasmussen BB.

Transl Sports Med. 2019 Apr;2(3):109-119. doi: 10.1002/tsm2.70. Epub 2019 Feb 20.

41.

Learner-adapted practice promotes skill transfer in unskilled adults learning the basketball set shot.

Porter C, Greenwood D, Panchuk D, Pepping GJ.

Eur J Sport Sci. 2019 May 11:1-11. doi: 10.1080/17461391.2019.1611931. [Epub ahead of print]

PMID:
31079552
42.

Editorial Comment.

Porter CR.

J Urol. 2019 Aug;202(2):270. doi: 10.1097/01.JU.0000559631.55370.8a. Epub 2019 Jul 8. No abstract available.

PMID:
31075064
43.

Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics.

Porter CK, Riddle MS, Gutierrez RL, Princen F, Strauss R, Telesco SE, Torres J, Choung RS, Laird RM, Leon F, Colombel JF, Murray JA; PREDICTS study team.

Contemp Clin Trials Commun. 2019 Mar 26;14:100345. doi: 10.1016/j.conctc.2019.100345. eCollection 2019 Jun.

44.

Clinical endpoints for efficacy studies.

Porter CK, Gutierrez RL, Kotloff KL.

Vaccine. 2019 Aug 7;37(34):4814-4822. doi: 10.1016/j.vaccine.2019.03.051. Epub 2019 Apr 10.

45.

Author Correction: Design, execution, and analysis of CRISPR-Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans.

Halder V, Porter CBM, Chavez A, Shapiro RS.

Nat Protoc. 2019 Aug;14(8):2595. doi: 10.1038/s41596-019-0157-3.

PMID:
30976123
46.

The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.

Koziolek M, Alcaro S, Augustijns P, Basit AW, Grimm M, Hens B, Hoad CL, Jedamzik P, Madla CM, Maliepaard M, Marciani L, Maruca A, Parrott N, Pávek P, Porter CJH, Reppas C, van Riet-Nales D, Rubbens J, Statelova M, Trevaskis NL, Valentová K, Vertzoni M, Čepo DV, Corsetti M.

Eur J Pharm Sci. 2019 Jun 15;134:31-59. doi: 10.1016/j.ejps.2019.04.003. Epub 2019 Apr 8. Review.

47.

Assessing health impacts of home food gardens with Wind River Indian Reservation families: protocol for a randomised controlled trial.

Porter CM, Wechsler AM, Naschold F, Hime SJ, Fox L.

BMJ Open. 2019 Apr 3;9(4):e022731. doi: 10.1136/bmjopen-2018-022731.

48.

Validation of the Complexity Assessment and Monitoring to Ensure Optimal Outcomes (CAMEO II) Acuity Tool for Pediatric Critical Care Nursing.

Connor JA, LaGrasta C, Gauvreau K, Porter C, Hickey PA.

Dimens Crit Care Nurs. 2019 May/Jun;38(3):153-159. doi: 10.1097/DCC.0000000000000355.

PMID:
30946124
49.

Scaling the Measurement of Pediatric Acuity Using the Complexity Assessment and Monitoring to Ensure Optimal Outcomes (CAMEO II) Tool.

Connor JA, LaGrasta C, Gauvreau K, Porter C, OʼBrien K, Hickey PA.

Dimens Crit Care Nurs. 2019 May/Jun;38(3):146-152. doi: 10.1097/DCC.0000000000000356.

PMID:
30946123
50.

Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.

Savarino SJ, McKenzie R, Tribble DR, Porter CK, O'Dowd A, Sincock SA, Poole ST, DeNearing B, Woods CM, Kim H, Grahek SL, Brinkley C, Crabb JH, Bourgeois AL.

J Infect Dis. 2019 Jul 2;220(3):505-513. doi: 10.1093/infdis/jiz135.

PMID:
30897198

Supplemental Content

Loading ...
Support Center